Geulah Livshits, PhD

Geulah Livshits, PhD is a biotech equity research analyst with a focus on advanced therapeutics in the oncology and gene editing spaces. With a BS in Biology from Brandeis University and a PhD in Molecular cell biology and development from Rockefeller University, Livshits is a well-educated professional with a deep understanding of biology and biotech. She has also studied in Stony Brook University's Fundamentals of the Bioscience Industry Program.

Livshits has amassed a significant amount of professional experience across various organizations in the biotech industry. She is currently a Senior Research Analyst at Chardan, where she concentrates on biotech equity research. Prior to that, she was a Senior Research Associate at the same company. Livshits worked as an intern at Chardan Capital Markets, LLC before she was hired. Additionally, she has been a consultant at The Solution Lab, Inc. and a postdoctoral fellow at Memorial Sloan Kettering Cancer Center.

Livshits is an expert in advanced therapeutics with specific proficiency in oncology and gene editing. Her skills include equity research analysis, strategic consulting, and scientific research. She enjoys staying up-to-date on the latest biotech advancements and is passionate about helping companies in the industry prosper.